• / Free eNewsletters & Magazine
  • / My Account
Home>G-7

G-7

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Chemotherapy Induced Nausea & Vomiting Global Clinical Trials Review, H1, 2016 - Analysis, Technologies & Forecasts - Key Vendors: Merck, Tesaro, Eisai - Research and Markets

    Chemotherapy Induced Nausea & Vomiting Global Clinical Trials Review, H1, 2016 - Analysis, Technologies & Forecasts - Key Vendors: Merck, Tesaro, Eisai - Research and Markets

  2. Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H1, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Allergan, Pfizer, ICStudy - Research and Markets

    Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H1, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Allergan, Pfizer, ICStudy - Research and Markets

  3. A.M. BestTV: Mutual Insurers Challenged to Step Up to Meet Global Risks

    A.M. BestTV: Mutual Insurers Challenged to Step Up to Meet Global Risks

  4. Overall Business Confidence in Ottawa Jumps on Strong Sector Performance – Ottawa Chamber of Commerce Survey

    Overall Business Confidence in Ottawa Jumps on Strong Sector Performance – Ottawa Chamber of Commerce Survey

  5. Has Quantitative Easing Given Labor Markets a Bump?

    Last year, G7 nations that implemented aggressive QE programs saw their unemployment rates drop by more than 1%, while those that didn't saw their rates increase or stay the same.

  6. Taking a Strategic Approach to Currency Exposure

    A surging dollar aside, think risk first when it comes to currency exposure.

  7. Taking a Strategic Approach to Currency Exposure

    A surging dollar aside, think risk first when it comes to currency exposure.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.